1. Home
  2. IBRX vs AN Comparison

IBRX vs AN Comparison

Compare IBRX & AN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$7.24

Market Cap

7.2B

Sector

Health Care

ML Signal

HOLD

Logo AutoNation Inc.

AN

AutoNation Inc.

HOLD

Current Price

$208.66

Market Cap

6.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBRX
AN
Founded
2014
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
6.4B
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
IBRX
AN
Price
$7.24
$208.66
Analyst Decision
Strong Buy
Buy
Analyst Count
7
9
Target Price
$12.57
$244.33
AVG Volume (30 Days)
9.4M
356.1K
Earning Date
05-08-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
38.71
0.71
EPS
N/A
5.85
Revenue
$113,288,000.00
$27,631,400,000.00
Revenue This Year
$88.59
$4.32
Revenue Next Year
$131.15
$2.89
P/E Ratio
N/A
$37.31
Revenue Growth
668.31
3.24
52 Week Low
$1.95
$176.62
52 Week High
$12.43
$235.81

Technical Indicators

Market Signals
Indicator
IBRX
AN
Relative Strength Index (RSI) 44.27 50.91
Support Level $6.69 $202.40
Resistance Level $8.46 $218.10
Average True Range (ATR) 0.42 8.32
MACD -0.09 0.99
Stochastic Oscillator 38.93 26.53

Price Performance

Historical Comparison
IBRX
AN

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

About AN AutoNation Inc.

AutoNation is the second-largest automotive dealer in the United States, with 2025 revenue of $27.6 billion and over 240 dealerships, plus 52 collision centers. The firm also has 26 AutoNation USA used-vehicle stores, a captive lender, four auction sites, and three parts distributors across 20 states primarily in Sunbelt metropolitan areas. New-vehicle sales account for nearly half of revenue; the company also sells used vehicles, parts, and repair services as well as auto financing. The company (formerly Republic Industries) divested its waste management unit (Republic Services) in 1999 and its car rental businesses (ANC Rental) in 2000. Wayne Huizenga founded the company in the 1990s to bring the rollup acquisition strategy to auto retailing, which has proved to be a smart move.

Share on Social Networks: